Unknown

Dataset Information

Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer.


ABSTRACT:

Background

Adaptive magnetic resonance imaging-guided radiation therapy (MRgRT) can escalate dose to tumors while minimizing dose to normal tissue. We evaluated outcomes of inoperable pancreatic cancer patients treated using MRgRT with and without dose escalation.

Methods

We reviewed 44 patients with inoperable pancreatic cancer treated with MRgRT. Treatments included conventional fractionation, hypofractionation, and stereotactic body radiation therapy. Patients were stratified into high-dose (biologically effective dose [BED10 ] >70) and standard-dose groups (BED10 ≤70). Overall survival (OS), freedom from local failure (FFLF) and freedom from distant failure (FFDF) were evaluated using Kaplan-Meier method. Cox regression was performed to identify pre

SUBMITTER: Rudra S 

PROVIDER: S-EPMC6536981 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature